DNA-guided hepatitis B treatment, viral load is essential, but not sufficient
Open Access
- 1 January 2009
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (4) , 423-430
Abstract
DNA-guided hepatitis B treatment, viral load is essential, but not sufficientKeywords
This publication has 78 references indexed in Scilit:
- Virologic and Histologic Features of Chronic Hepatitis B Virus-Infected Asymptomatic Patients With Persistently Normal ALTGastroenterology, 2008
- The clinical significance of persistently normal ALT in chronic hepatitis B infectionJournal of Hepatology, 2007
- Antiviral drug-resistant HBVHepatology, 2007
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis BGut, 2006
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: A pilot studyThe Journal of Pediatrics, 2006
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literatureJournal of Hepatology, 1993
- Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective studyLiver International, 1989